NeoGenomics, Inc.
NEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.6% | 7.9% | -2.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 42.8% | 42.6% | 43.6% | 44.9% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -5.3% | -15.2% | -3.8% | 2.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -14.4% | -24.9% | -15.4% | -8.9% |
| EPS Diluted | -1.05 | -1.75 | -1 | -0.6 |
| % Growth | 40% | -75% | -66.7% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |